Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy

Published:2013-10 Issue:10 Volume:24 Page:824-839
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

De Oliveira Satiro Nakamura¹,Ryan Christine²,Giannoni Francesca²,Hardee Cinnamon L.²,Tremcinska Irena²,Katebian Behrod²,Wherley Jennifer²,Sahaghian Arineh²,Tu Andy¹,Grogan Tristan³,Elashoff David³,Cooper Laurence J.N.⁴,Hollis Roger P.²,Kohn Donald B.¹²

Affiliation:

1. Division of Hematology/Oncology, Department of Pediatrics, University of California–Los Angeles, Los Angeles, CA 90095.

2. Department of Microbiology, Immunology and Molecular Genetics, University of California–Los Angeles, Los Angeles, CA 90095.

3. Department of Medicine Statistics Core, David Geffen School of Medicine, University of California–Los Angeles, Los Angeles, CA 90095.

4. Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX 77030.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2012.202

Reference42 articles.

1. 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells

2. Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo

3. Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

4. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

5. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review;Pathology - Research and Practice;2024-10

2. Efficient generation of CAR NK cells from human umbilical cord blood CD34⁺stem and progenitors for democratizing affordable immunotherapy;2024-07-30

3. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

4. Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells;Molecular Therapy;2024-04

5. Harnessing bioengineered myeloid progenitors for precision immunotherapies;npj Regenerative Medicine;2023-12-12